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Abstract: The purinergic system plays a role in the regulation of mood, motor 
activity, cognitive function, sleep, and behavior. Purinergic mechanisms can also 
play a role in various neuropsychiatric diseases. The objective of this study is to 
assess whether uric acid levels in patients with unipolar and bipolar depression are 
different in comparison to healthy controls and to determine the clinical parameters 
that can be associated with the uric acid level. This retrospective study consisted of 
31 patients with major depressive disorder and 31 patients with bipolar disorder 
depressive episode and 31 healthy control subjects. The mean serum uric acid 
levels were found as follows: major depression patient group 4.56 (± 1.53) mg/dL, 
bipolar depression patient group 5.38 (± 1.43) mg/dL and control group 4.86 (± 1.56) 
mg/dL. There was no significant difference between patients and the control groups 
in terms of serum uric acid levels (P=0.075). Serum uric acid levels do not differ 
significantly in bipolar and unipolar depression. Also, there was no difference 
between patients and control. Therefore, studying the uric acid metabolism in major 
depression and bipolar disorder depressive episode according to the symptom 
severity with larger sample groups is suggested. 
Keywords: bipolar disorder; major depressive disorder; uric acid; purinergic 
dysfunction; inflammation 
 
INTRODUCTION 
The purinergic system plays a role in the regulation of mood, motor activity, 
cognitive function, sleep, and behavior. Purinergic mechanisms can also play a role 
in various neuropsychiatric diseases (Ortiz R. et al. 2015, Cheffer A. et al. 2018). 
Uric acid is the end product of purine metabolism associated with the activity of 
xanthine oxidase enzyme on xanthine and hypoxanthine (Grassi D. 2013). Purines 
such as adenosine and ATP also play an important role in neurotransmission and 
neuromodulation. They show these effects via P1 and P2 receptors (Burnstock G. 
2011). It demonstrated that especially adenosine agonists have antimanic (sedative, 
anticonvulsant, aggression relieving, etc.) effects. It sees that uric acid levels could 
use as indirect markers for showing increased purinergic turnover and decreased 
adenosine levels in patients with bipolar disorder (Machado Vieira R. 2008, 2012). In 
the studies conducted, uric acid was also found to be associated with altered 
behavior such as impulsivity, aggressive behavior, and hyperthymic temperament 
(Ortiz R. et al. 2015). On the other hand, uric acid is a significant antioxidant (Sautin 
YY & Johnson RJ. 2008). Studies show that Allopurinol that is xanthine oxidase 
inhibitor using for hyperuricemia can use as reducing mania symptoms in bipolar 
disorder as add-on treatments (Bartoli F. 2017).  
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Plasma uric acid levels were found to be lower in unipolar depressive 
disorders (Black CN., 2018). Meta-analyses found that plasma uric acid levels found 
to be higher in bipolar disorder patients than healthy controls (Bartoli F. 2016). So 
recent studies focused on uric acid levels in bipolar depressive episode, and 
differences of uric acid levels in bipolar and unipolar depression. A study suggested 
that higher uric acid levels increase the risk for bipolar disorder (Dos Santos Oliveira 
PM. 2018). A study found that the uric acid levels are reduced in unipolar depression 
and elevated in bipolar disorder in remission (Kesebir. 2014). To contribute to clarify 
of association between uric acid levels and bipolar/unipolar depression, we 
investigated bipolar and unipolar depression patients in the active period.  The 
objective of this study is to assess whether uric acid levels in patients with unipolar 
and bipolar depression are different in comparison to healthy controls and to 
determine the clinical parameters that can be associated with a uric acid level.  
 
MATERIALS AND METHODS  
The study included patient groups consisting of 31 inpatients diagnosed with 
major depressive disorder and 31 inpatients diagnosed with bipolar disorder 
depressive episode in the department of psychiatry of Gaziantep University Medicine 
Faculty in Turkey between April 2015 and November 2017, and a control group of 31 
healthy individuals without any known history of psychiatric disorders. This study 
approved with Gaziantep University ethics committee. Patient diagnoses determined 
according to DSM-V, and Hamilton Depression Rating Scale (HamD) used for 
assessing the disease severity. HamD is a questionnaire which consist 21 items and 
was developed to assess depression severity. The reliability and validity study 
conducted in Turkish (Akdemir. 2001). The patient exclusion criteria were as follows 
using drugs (lithium, antidepressants, and diuretics) that might affect uric acid 
metabolism, gout disease, hypothyroidism, alcohol use disorder, chronic kidney 
disease, diabetes, active malignancies, any active metabolic or infectious disease 
using corticosteroid.  
Plasma uric acid levels of all groups recorded after reviewing the existing 
medical records. Venous blood sample had been taken from the antecubital vein. 
Plasma uric acid levels had been measured in mg/dl in the same day by 
spectrophotometric method. Statistical power analysis does, and 31 patients were 
found enough for each group. Normal distribution of numerical data was tested by 
the Shapiro–Wilk test. Mann-Whitney U Test was used to compare variables that did 
not have a normal distribution in two groups. ANOVA test used in the comparison of 
the variables that had normal distribution. SPSS 22.0 package software used for the 
analyses. P<0.05 was accepted as statistically significant. 
 
RESULTS AND DISCUSSION 
Totally 62 patients and 31 healthy subjects included in this study. In the 
patient group, 51% (32) were females, and 49% (30) were males. The mean age of 
the patients included in our study was 40.67. There were no significant differences 
between groups in terms of mean patient age, marital status, education years, and 
smoking. The mean serum uric acid levels found as follows: major depression 
patient group 4.56 (±1.53) mg/dl, bipolar depression patient group 5.38 (± 1.43) 
mg/dL and control group 4.86 (±1.56) mg/dl. Descriptive statistics of the study shown 
in Tables 1 and 2.  
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Table 1. Descriptive statistics 
      Count    % 
Patient' subtype 
 
Bipolar depression 31 33,3 
Major depression 31 33,3 
Control group  31 33,3 
Gender Female 48 51,6 
Male 45 48,4 
 
 
Table 2. Descriptive statistics 
            N           Min 
          
Max    Mean 
               
St. Dev. 
HAM-D 62 13,00 39,00 25,4355 5,62087 
Uric Acid 93 0,80 9,40 4,9376 1,43980 
            HAM-D: Hamilton Depression Rating Scale 
            St. Dev: Standard deviation 
 
Although serum uric acid levels seem to be higher in the bipolar depression 
group comparison to significant depression and healthy controls (p= 0.062, 0.055 
respectively), it wasn’t significant (P=0.075). (Table 3). There were no significant 
differences between uric acid levels in terms of age, gender, and duration of disease.  
 
Table 3. Statistical analysis of uric acid levels between control, bipolar depression 
and major depression groups 
 
Studies show that inflammatory activity increases in depression (Varma G. S. 
2014). Also, studies conducted between the years 1967-2008 reviewed in meta-
analyses and seen that there was a positive correlation between depression and 
CRP, IL-6, and IL-1 (Howren MB. 2009). In another metaanalysis, studies conducted 
between the years 1960-2009 were reviewed, patients that were on antidepressants 
it was found that TNF-α levels were higher in the depression group in comparison to 
the control group, IL-6 levels were higher in the patient group in comparison to the 
control group and IL-1β levels did not differ between patient and control groups 
(Dowlati Y et al. 2010). In addition to these results, in a study conducted on 
schizoaffective disorder, it was found that hs-CRP levels were higher during the 
depressive phase, and IL-4 levels were lower during the manic period in comparison 
to the control group, both of which support immune system activation in affective 
disorders (Elboga G et al. 2017). It also is shown that uric acid level elevated during 
the inflammatory process. The studies conducted revealed a significantly positive 
correlation between uric acid levels and several inflammatory markers (Ruggiero C 
et al. 2006). In our research, there were no significant differences in major 
 N mean St. Dev P 
Uric 
Acid 
 Bipolar depression 31 5,3839 1,42363 0,075 
 Major depression 31 4,5645 1,53743 
 Control group 31 4,8645 1,26953 
 Total 93 4,9376 1,43980 
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depression, healthy controls, and bipolar depression group in terms of uric acid 
levels. It might be associated with a limited sample group.  
Besides cross-sectional design, lack of control for important factors that may 
influence uric acid (alcohol use, caffeine, dietary patterns, BMI) is also a limitation of 
this study. In particular, it shown that uric acid may include variations in subjects with 
bipolar disorder may be at least partially due to metabolic abnormalities.  
Uric acid is a significant antioxidant (Sautin YY & Johnson RJ. 2008). There is 
evidence about an alteration of oxidative parameters indicating the oxidant system in 
both bipolar and unipolar depression (Sahin S et al. 2017, Bulut M et al. 2013). But 
when we consider no differences in uric aside levels between patients and control, 
this change in the oxidant system may be attributable to the oxidative parameters of 
non-uric acid. 
In the literature, some studies support the opinion that uric acid levels are 
altered in depression patients (Bartoli F. et al. 2016) A research has shown that the 
uric acid level is reduced in unipolar depression and elevated in bipolar disorder due 
to purine metabolism disorder. However, in this study, uric acid was evaluated in 
patients in remission (Kesebir S. 2014). The lack of difference in our study may be 
an indication that the antioxidant system is not working well in the active period of 
disorders. The major limitation is that in these studies, patients are taking 
medication. Also, uric acid levels are associated with metabolic syndrome and 
metabolic syndrome prevalence is high in psychiatric disorders and antipsychotics 
(Sahin et al. 2018, Chaudhary et al. 2013). So another limitation of this study is that 
patients’ body mass index is unknown. Non-medicated patients and large scale 
studies are needed. 
 
CONCLUSION 
Alterations in uric acid levels may not be a predictive marker for the 
differentiation of major depression and bipolar depression. Examination of uric acid 
metabolism in patients with major depressive disorder and bipolar disorder 
depressive episode according to the symptom severity may contribute to the 
understanding of the disease in larger sample groups and may broaden the horizons 
of differential diagnosis and treatment. 
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